153 related articles for article (PubMed ID: 25167577)
1. [Peptide vaccination in glioblastoma].
Terasaki M; Morioka M
Gan To Kagaku Ryoho; 2014 Jun; 41(6):725-9. PubMed ID: 25167577
[No Abstract] [Full Text] [Related]
2. Clinical applications of a peptide-based vaccine for glioblastoma.
Kanaly CW; Ding D; Heimberger AB; Sampson JH
Neurosurg Clin N Am; 2010 Jan; 21(1):95-109. PubMed ID: 19944970
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy offers a promising bet against brain cancer.
Eisenstein M
Nature; 2018 Sep; 561(7724):S42-S44. PubMed ID: 30258155
[No Abstract] [Full Text] [Related]
4. Early-stage progress on glioma vaccines.
Brower V
J Natl Cancer Inst; 2011 Sep; 103(18):1361-2. PubMed ID: 21881038
[No Abstract] [Full Text] [Related]
5. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
Narita Y; Arakawa Y; Yamasaki F; Nishikawa R; Aoki T; Kanamori M; Nagane M; Kumabe T; Hirose Y; Ichikawa T; Kobayashi H; Fujimaki T; Goto H; Takeshima H; Ueba T; Abe H; Tamiya T; Sonoda Y; Natsume A; Kakuma T; Sugita Y; Komatsu N; Yamada A; Sasada T; Matsueda S; Shichijo S; Itoh K; Terasaki M
Neuro Oncol; 2019 Feb; 21(3):348-359. PubMed ID: 30500939
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
[TBL] [Abstract][Full Text] [Related]
7. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
Khansur E; Shah AH; Lacy K; Komotar RJ
Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
[TBL] [Abstract][Full Text] [Related]
8. Heat shock proteins in glioblastomas.
Yang I; Fang S; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
[TBL] [Abstract][Full Text] [Related]
9. Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.
Del Vecchio CA; Wong AJ
Curr Opin Mol Ther; 2010 Dec; 12(6):741-54. PubMed ID: 21154166
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events.
Lowenstein PR
J Clin Oncol; 2010 Nov; 28(31):4670-3. PubMed ID: 20921460
[No Abstract] [Full Text] [Related]
11. [II. Autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma].
Maruyama T; Muragaki Y; Ishikawa E; Nitta M; Saito T; Ohno T; Iseki H; Okada Y
Gan To Kagaku Ryoho; 2015 Jun; 42(6):683-6. PubMed ID: 26242005
[No Abstract] [Full Text] [Related]
12. Immunological challenges for peptide-based immunotherapy in glioblastoma.
Mohme M; Neidert MC; Regli L; Weller M; Martin R
Cancer Treat Rev; 2014 Mar; 40(2):248-58. PubMed ID: 24064197
[TBL] [Abstract][Full Text] [Related]
13. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.
Wheeler CJ; Das A; Liu G; Yu JS; Black KL
Clin Cancer Res; 2004 Aug; 10(16):5316-26. PubMed ID: 15328167
[TBL] [Abstract][Full Text] [Related]
14. [II.Current status of peptide vaccine for lung cancer].
Suzuki H
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1009- 14. PubMed ID: 24151657
[No Abstract] [Full Text] [Related]
15. [III. Peptide vaccination therapy against brain tumors].
Hashimoto N; Kagawa N; Arita H; Tsuboi A; Oka Y; Oji Y; Sugiyama H; Yoshimine T
Gan To Kagaku Ryoho; 2015 Jun; 42(6):687-9. PubMed ID: 26242006
[No Abstract] [Full Text] [Related]
16. Peptide vaccine therapy for childhood gliomas.
Pollack IF; Jakacki RI; Butterfield LH; Okada H
Neurosurgery; 2013 Aug; 60 Suppl 1():113-9. PubMed ID: 23839362
[No Abstract] [Full Text] [Related]
17. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
Van Gool S; De Vleeschouwer S
Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
[No Abstract] [Full Text] [Related]
18. Prospect of rindopepimut in the treatment of glioblastoma.
Elsamadicy AA; Chongsathidkiet P; Desai R; Woroniecka K; Farber SH; Fecci PE; Sampson JH
Expert Opin Biol Ther; 2017 Apr; 17(4):507-513. PubMed ID: 28274144
[TBL] [Abstract][Full Text] [Related]
19. Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.
Del Vecchio CA; Li G; Wong AJ
Expert Rev Vaccines; 2012 Feb; 11(2):133-44. PubMed ID: 22309662
[TBL] [Abstract][Full Text] [Related]
20. Methods of resistance to epidermal growth factor receptor inhibition in glioblastoma multiforme.
Komotar RJ; Starke RM; Connolly ES; Sisti MB
Neurosurgery; 2012 Feb; 70(2):N13-4. PubMed ID: 22251981
[No Abstract] [Full Text] [Related]
[Next] [New Search]